Generalized myoclonus in COVID-19.

Pablo Rábano-SuárezLaura Bermejo-GuerreroAntonio Méndez-GuerreroJavier Parra-SerranoDaniel Toledo-AlfoceaDaniel Sánchez-TejerinaTeresa Santos-FernándezMaría Dolores Folgueira-LópezJudit Gutiérrez-GutiérrezBlanca Ayuso-GarcíaJesús González de la AlejaJulián Benito-León

Published in: Neurology (2020)

Our 3 cases highlight the occurrence of myoclonus during the COVID-19 pandemic as a post- or para-infectious immune-mediated disorder. However, we cannot rule out that SARS-CoV-2 may spread transneuronally to first- and second-order structures connected with the olfactory bulb. Further investigation is required to clarify the full clinical spectrum of neurologic symptoms and optimal treatment.

Keyphrases

sars cov
respiratory syndrome coronavirus
coronavirus disease
risk assessment
high resolution
physical activity
depressive symptoms
combination therapy
replacement therapy